Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Roflumilast vs Methotrexate in Psoriasis
NCT05684744Phase 3Completed
- Sponsor
- Cairo University
- Start
- Jan 2023
- Primary completion
- May 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of roflumilast in psoriasis, sponsored by Cairo University. Started Jan 2023; status: completed.
02
Drugs
roflumilast
03
Conditions
psoriasis
Beyond the preview
Go deeper on NCT05684744.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05684744.